Diabetes

NEW YORK — CVS/pharmacy. Rite Aid. Walgreens. Sam’s Club. Ahold. H-E-B. The Katz Group. Giant Eagle. Good Neighbor. Health Mart. The list of participating companies in the 13th Annual Drug Store News Group Industry Issues conference — which will be held Tuesday, Nov. 29, here at the highly prestigious New York Athletic Club — reads like a “who’s who” of pharmacy retailing.

NEW YORK — A new app for the iPhone allows users to keep track of their blood-sugar levels on a daily basis, according to published reports.

Glooko has launched the logbook app and MeterSync cable, which allow patients to automatically download data from their blood-glucose meters to their iPhones, add notes and send results to their healthcare providers.

The cable costs $40 and works with popular glucose meters made by Bayer, FreeStyle and OneTouch.

BUFFALO, N.Y. — A drug commonly prescribed to Type 2 diabetics to improve blood-sugar control also may have a rapid anti-inflammatory effect, according to results from a small study conducted by researchers at the University of Buffalo.

CAMP HILL, Pa. — Women, more often than men, reported that diabetes had a greater negative impact on their emotional outlook as well as their compliance with diet and exercise recommendations, according to a study released Thursday by Rite Aid and WebMD. The survey also found that women were more open than men to receiving tools to help them manage their diabetes.

MINNETONKA, Minn. — The UnitedHealth Group’s Diabetes Prevention and Control Alliance is emphasizing its Not Me program — an employer- and community-based initiative aimed at combating the epidemic of Type 2 diabetes, prediabetes and obesity — in line with National Diabetes Month.

NEW YORK — Teenagers that consume a fiber-rich diet are less likely to develop metabolic syndrome, according to a new study published in the Journal of the American Dietetic Association.

SAN DIEGO — Eli Lilly and Amylin Pharmaceuticals are ending their diabetes-drug alliance, the two companies said Tuesday.

Indianapolis-based Lilly and San Diego-based Amylin said they would terminate their alliance concerning exenatide, the active ingredient in the injected diabetes drug Byetta and its long-acting version, Bydureon, currently under investigation.

NEW YORK — Sweet'N Low and Olympic athlete Dominique Dawes have joined forces to address the growing diabetes epidemic in honor of National Diabetes Month.